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SUMMARY. The prevalence of heterotopic gastric mucosa of the upper esophagus (inlet patch) has a wide range
depending on the method and detail of examination. The inlet patch is believed to be a congenital malformation that
rarely leads to symptoms. We aimed to quantify the prevalence of the inlet patch in a non-referred population and
determine if there are any risk factors or associated symptoms. Men between ages 50 and 79 presenting for routine
colonoscopy at two clinical sites were recruited to undergo an upper endoscopy. Endoscopists were prompted to
examine for the presence of the inlet patch. Of the 822 enrolled patients, 795 had data regarding the presence of
an inlet patch. Of these, 55 (6.9%) had an inlet patch identified. Education was inversely associated (odds ratio
[OR] advanced degree vs. high school or less = 0.310; 95% confidence interval [CI] = 0.111, 0.869), and tobacco use
was positively associated with the presence of an inlet patch (current vs. never smokers OR = 2.87; 95% CI = 1.23,
6.69; former vs. never smokers OR = 1.93; 95% CI = 0.922, 4.02). No association between the inlet patch and
symptoms of heartburn, globus, or dysphagia was found. In a cross-sectional study of colon cancer screenees, inlet
patches were common and were not associated with symptoms. Tobacco use appears to be associated with the
presence of an inlet patch.
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INTRODUCTION
An inlet patch is defined as gastric heterotopic
mucosa in the upper esophagus; the condition was
first described more than a century ago.1 In prior
studies, the prevalence ranges broadly from 0.3% to
10% of endoscopies, likely due to how carefully the
upper esophagus is examined.2–4 While a majority
of patients are asymptomatic, symptoms of globus
and dysphagia have been associated with these endo-
scopic findings,5 and complications associated with
the inlet patch in the literature include stricture, fis-
tulas, adenocarcinoma, and perforation.6–8
The finding itself is believed to be congenital, but
associations with alcohol use and Barrett’s esophagus
have been found.9 To our knowledge, no association
with tobacco has been reported in the literature.
We recently completed a large prospective study
designed to assess risk factors for Barrett’s esophagus.
In that study, 822 men between the ages of 50 and 79
undergoing routine colonoscopy for colorectal cancer
screening also underwent an upper endoscopy regard-
less of symptoms and a battery of surveys. As part of
that study, endoscopists were directed by a research
coordinator specifically to examine for the presence of
an inlet patch. This study provided a unique opportu-
nity to quantify the prevalence of the inlet patch and
determine if there are any risk factors to suggest that
it is an acquired condition, and to determine whether
inlet patches are associated with symptoms.
METHODS
Men between the ages of 50 and 79 were enrolled
in the Newly Diagnosed Barrett’s Esophagus Study
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from February 2008 to December 2011. These pati-
ents were presenting for screening or surveillance
colonoscopy at the Ann Arbor Veteran’s Affairs
Medical Center or the University of Michigan’s East
Ann Arbor Medical Procedures Center. The study
design is described in detail elsewhere.10,11 Briefly,
patients were excluded if their age was not within
50–79 years, if they were female, if they had under-
gone prior upper endoscopy, or had a prior history
of Barrett’s esophagus or esophagectomy. If the
colonoscopy was being done for bleeding (includ-
ing occult blood), iron deficiency anemia, diarrhea,
and inflammatory bowel disease-related surveillance,
patients were also excluded. Those with a history of
ascites, esophageal varices, history of cancer in the
last 5 years (except non-melanomatous skin cancers),
or those who were inpatients were excluded.
Prior to endoscopy, patient’s height, weight, and
hip circumference were measured in duplicate.
Patients were then questioned regarding alcohol,
tobacco, and medication use in addition to gastroin-
testinal symptoms. A novel questionnaire regarding
gastroesophageal reflux disease (GERD) symptoms
was administered. Alternative instruments available
at the time of initiation of the study, such as theMayo
Gastroesophageal Reflux Questionnaire, did not dis-
criminate between past history of reflux symptoms
and the use of histamine receptor blockers and
proton pump inhibitors (PPI). Portions of this ques-
tionnaire can be found in the supplementary material
for the original paper.10 For the purposes of this
analysis, we utilized responses to queries regarding
time since onset of heartburn symptoms, and typical
frequency of either heartburn or regurgitation while
not taking acid-reducing medications. Questions
regarding globus sensation, defined as the sensation
of something lodged in the patient’s throat when not
eating or drinking, and dysphagia were also included
in the questionnaire. Detailed questions regarding
dysphagia to type (solids, liquids, or pills), location,
and frequency were asked; for the purpose of our
analysis, we characterized dysphagia only as the
dichotomous answer to a query regarding problems
with swallowing. The questions regarding heartburn,
regurgitation, globus, and dysphagia were adminis-
tered by a research assistant prior to the endoscopy
procedure. The remaining questions, including
regarding tobacco use, were typically completed by
the subjects after the procedure at home and returned
by postal mail.
The research assistant queried the endoscopist in
each case regarding findings and measurements. The
endoscopist was asked specifically to examine for the
presence of an inlet patch using both white light
and narrow band imaging. If one was found, the
location, size (circumferential aspect), and distance
to proximal and distal aspects of the patch were
recorded. Biopsies were not routinely obtained of an
inlet patch. If Barrett’s esophagus was suspected
endoscopically, biopsies were obtained and reviewed
by a pathologist with expertise in Barrett’s esopha-
gus. Patients with columnar mucosa in the distal
esophagus identified endoscopically and confirmed to
harbor specialized intestinal metaplasia on histology
were classified to have Barrett’s esophagus. There
were trainees involved in some procedures, but this
information was not recorded so the percentage of
procedures and how this affected the findings of an
inlet patch are unknown. An attending physician was
always present for these endoscopies.
Analysis
Data were recorded in Microsoft Access and then
imported to SAS 9.3 for analysis (Sas Inc., Cary, NC,
USA). Chi-square or Fisher’s exact tests were used
where statistically appropriate to compare categori-
cal variables, and the student’s t-test was used to
analyze continuous variables. Linear trends where
analyzed by the Mantel–Haenszel chi-square test
after ensuring that all cells had expected values
greater than 5. Logistic regression models were fitted
adjusting for potential confounders.
RESULTS
Of the 822 patients enrolled, 463 were from the uni-
versity site and 359 were from the Veteran’s Affairs
Medical Center. Of these 822, 27 patients had missing
data on the presence of the inlet patch (3.3%). Of these
27 patients, three cases specifically noted difficulty in
assessing for the presence of a patch due to patient
intolerance. Of the remaining 795, 55 had an inlet
patch on endoscopy (6.9%). While most patients had
only one patch (85.5%), one patient did have four
distinct patches (Fig. 1). The majority of patients had
a patch that encompassed less than 25%of the circum-
ference andmostwere less than 2 cm in length (Fig. 1).
Inlet patchwasmost likely to be found on the patient’s
left than any other location (P = 0.03). Further details
about the number of patches per patient, location,
length, circumference, and distance from the upper
esophageal sphincter are found in Figure 1.
Demographics were similar for those with and
without inlet patch, with the exception of education
which was inversely associated with inlet patch (33%
had high school education or less vs. 20%, Table 1).
There was no difference in age, race, household
income, body mass index, or waist-hip ratio between
the two groups. Of the 822 patients, 16 (2%) did not
complete any portion of our GERD questionnaire.
There were no statistically significant differences
between those with and without inlet patches with
regard to symptoms, including heartburn, globus,
or dysphagia (Table 1). Examining only those with
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Fig. 1 Characteristics of the inlet patch findings. A pie chart of the number of inlet patches found per patient is located in panel (a).
Panel (b) a histogram (absolute counts) of the inlet patch length from proximal to distal edge in centimeters. Panel (c) shows the
distance from the upper esophageal sphincter to the proximal edge of the patch in centimeters. Panel (d) shows the distribution of the
patch location, with respect to the patient. Finally, panel (e) shows the percentage circumference that the patch encompasses in this
population.
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larger inlet patches (>1 cm in length or >25% of the
esophageal circumference) also did not reveal an
association with these symptoms. There was also
no difference in PPI use, type 2 histamine receptor
blocker use, aspirin use, or other non-steroidal anti
inflammatory drug use. Neither group was more
likely to have a hiatal hernia (>2 cm) or biopsy-
proven Barrett’s esophagus (Table 1).
Patients with inlet patches had a heavier smoking
history (mean 23.7 pack-years vs. 16.3 pack-years,
Table 1 Comparison of characteristics between patients with an inlet patch and those without a patch
Inlet patch (n = 55) No inlet patch (n = 740) P-value
Age (SD) 58.5 (6.5) 58.8 (6.8) 0.72
Race (%) 0.61
Caucasian 43 (93.5) 635 (89.8)
Not Caucasian 3 (6.5) 72 (10.2)
Education 0.05
High school or less 16 (33.3) 145 (20.4)
Some college up to bachelor’s degree 27 (56.3) 421 (59.1)
Advanced degree 5 (10.4) 146 (20.5)
Annual income ($) 0.64
<40 000 21 (44.7) 259 (38.8)
40 000–100 000 15 (31.9) 215 (32.2)
>100 000 11 (23.4) 194 (29.0)
Site (%) 0.39
MPC 28 (50.9) 421 (56.9)
VA 27 (49.1) 319 (43.1)
BMI (%) 0.32
BMI <20 1 (1.9) 7 (1.0)
BMI 20–25 11 (20.4) 123 (16.8)
BMI 25–30 24 (44.4) 266 (36.2)
BMI >30 18 (33.3) 338 (46.1)
Waist to hip ratio by tertiles 0.73
First (<0.979) 21 (38.2) 246 (33.3)
Second (0.980–1.024) 16 (29.1) 245 (33.1)
Third (>1.024) 18 (32.8) 248 (33.6)
Biopsy proven Barrett’s (%) 0.8
Yes 5 (9.1) 63 (8.5)
No 50 (90.9) 676 (91.5)
Hiatal hernia >2 cm 0.88
Yes 6 (11.1) 87 (11.8)
No 48 (88.9) 651 (88.2)
GERD frequency off meds 0.32
>1 weekly 13 (24.1) 135 (18.6)
Not weekly 41 (75.9) 590 (81.4)
Heartburn for 3 continuous months 0.7
Never 45 (83.3) 573 (79.3)
In the last year only 0 24 (3.3)
Started 1–3 years ago 2 (3.7) 27 (3.7)
Started >3 years ago 7 (13.0) 99 (13.7)
Globus 0.75
Yes 5 (9.3) 77 (10.6)
No 49 (90.7) 648 (89.4)
Dysphagia 0.49
Yes 4 (7.4) 75 (10.3)
No 40 (92.6) 650 (89.7)
ASA use 0.61
None 34 (61.8) 412 (55.7)
For <5 years 8 (14.6) 143 (19.3)
For ≥5 years 13 (23.6) 185 (25.0)
NSAID use 0.81
None 43 (78.2) 552 (74.6)
For <5 years 8 (14.6) 118 (16.0)
For ≥5 years 4 (7.3) 70 (9.0)
PPI use (%) 0.8
None 50 (90.9) 646 (87.3)
PPI <5 years 3 (5.5) 64 (8.7)
PPI >5 years 2 (3.6) 30 (4.0)
H2RA use (%) 0.77
None 50 (94.6) 693 (93.7)
H2RA <5 years 2 (3.6) 38 (5.1)
H2RA >5 years 1 (1.8) 9 (1.2)
ASA, aspirin; BMI, body mass index; GERD, gastroesophageal reflux disease; MPC, Medical Procedures Center; NSAID, non-steroidal
anti inflammatory drugs; PPI, proton pump inhibitor; VA, Veteran’s Affairs Medical Center.
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P = 0.006). Categorizing patients into groups with no
smoking history, light smoking history (<35 pack-
years), and heavy smoking history (≥35 pack-years),
there was also an association with smoking history
and the inlet patch (P = 0.02), along with evidence of
a linear trend between increasing exposure to ciga-
rettes and increased risk of having an inlet patch
(P = 0.01) (Table 2). Analyzing tobacco use further,
we found that there was a positive association
between current cigarette use and the finding of an
inlet patch (P = 0.04), again with a linear trend
showing that current cigarette users had a higher like-
lihood of having an inlet patch than former smokers,
who in turn had a higher likelihood than those who
never smoked. The odds ratio (OR) of inlet patch for
those who had quit recently (2.71, 95% confidence
interval [CI] = 1.01, 7.25) approximated the OR of
inlet patch for current smokers (2.84, 95% CI = 1.22,
6.63), while those who quit more than a decade ago
had an OR of 1.58 (95% CI = 0.711, 3.50), which was
not significantly different than patients who never
smoked (Table 2). Average typical alcohol intake per
week was not associated with the inlet patch.
We considered that the education effect might be
confounded by smoking on the prevalence of an inlet
patch, or vice versa. Smoking (categorized as never,
former, and current) was inversely correlated with
education (categorized as high school or less, at least
some college, or postgraduate degree) (P-value <
0.001). Table 3 presents the ORs for these effects con-
sidered with and without mutually adjusting for each
other. The estimate of the smoking effect was attenu-
ated toward the null after adjusting for education;
likewise, the estimate of the education effect was
also attenuated toward the null after adjusting for
smoking.
Table 2 The effects of tobacco and alcohol use on the presence of inlet patch
Inlet patch (n = 55) No inlet patch (n = 740) OR (95%CI) P-value
Pack-years of cigarettes 0.02
0 pack-years 12 (25.0) 241 (34.2) 1
1–34 pack-years 12 (25.0) 246 (34.9) 1.42 (0.623–3.21)
>35 pack-years 24 (50.0) 218 (30.9) 2.69 (1.31–5.52)
Linear trend 0.01
Smoking status
Never 11 (23.9) 281 (40.6) 1 0.04
Former 23 (50.0) 305 (44.0) 1.93 (0.922–4.02)
Current 12 (26.1) 107 (15.4) 2.87 (1.23–6.69)
Linear trend 0.01
Smoker by duration since use 0.06
Never 11 (24.4) 281 (40.3) 1
Quit >10 years ago 15 (33.3) 243 (34.8) 1.58 (0.711–3.50)
Quit <10 years ago 7 (15.6) 66 (9.5) 2.71 (1.01–7.25)
Current 12 (26.7) 108 (15.5) 2.84 (1.22–6.63)
Linear trend 0.007
Smoking status and duration
Never 11 (23.9) 281 (40.6) 1 0.04
Former, 1–34 pack-years 11 (23.9) 188 (27.1) 1.50 (0.635–3.52)
Former, >35 pack-years 12 (26.1) 117 (16.9) 2.62 (1.12–6.11)
Current 12 (26.1) 107 (15.4) 2.87 (1.23–6.69)
Linear trend 0.005
ETOH (drinks/week) 4.7 (7.2) 5.2 (7.8) — 0.65
ETOH, ethanol.
Table 3 Comparison of smoking and education status individually (crude) and in combination (adjusted)
n (%)
Crude estimates
OR (95%CI)
Adjusted estimates
OR (95%CI)Inlet patch No inlet patch
Smoking status (alone)
Never 11 (23.9) 281 (40.6) 1 1
Former 23 (50.0) 305 (44.0) 1.93 (0.922–4.02) 1.69 (0.788–3.62)
Current 12 (26.1) 107 (15.4) 2.87 (1.23–6.69) 2.02 (0.809–5.06)
P-value 0.05 0.27
Education status (alone)
High school or less 16 (33.3) 145 (20.4) 1 1
Some college up to bachelor’s degree 27 (56.3) 421 (59.1) 0.58 (0.304–1.11) 0.573 (0.292–1.13)
Advanced degree 5 (10.4) 146 (20.5) 0.31 (0.111–0.869) 0.418 (0.140–1.25)
P-value 0.06 0.17
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DISCUSSION
Most research has suggested that the inlet patch is
a congenital malformation, but there have been asso-
ciations noted in the past that may suggest it is
an acquired condition, including a previously found
association with Barrett’s esophagus and with
alcohol intake.9 That study failed to show an associa-
tion between the inlet patch and smoking but only
treated smoking as a dichotomous variable in the
analysis. The Newly Diagnosed Barrett’s Esophagus
Study provides a unique opportunity to examine the
prevalence and risk factors of gastric heterotopic
mucosa in the upper esophagus in a population
that more closely resembles the general population.
The prior endoscopic studies on this topic have typi-
cally been a sampling3,4 of patients presenting for
upper endoscopy for clinical indications, which likely
introduces an element of selection bias into the esti-
mate of the prevalence and associations. Addition-
ally, this study included detailed surveys of patient’s
symptoms, medications, and habits, allowing us to
determine if habits such as cigarette smoking are
associated with the inlet patch.
Our study did find a relationship between cigarette
use and the inlet patch. While the analysis here
is performed in a case-control fashion and so is not
sufficient to prove causation, there are several fea-
tures of our analysis that do suggest a causal link.
First, there was noted to be an increased risk as
the number of pack-years of cigarette use increases.
Second, former smokers had a lower prevalence
of inlet patches than those who currently smoked.
Third, those who had quit for more than 10 years had
a prevalence of inlet patch that closely approximated
that of the population who never smoked. However,
the association of inlet patch with tobacco may
have been confounded by education, which was also
inversely associated with inlet patch.
A number or prior studies have reported the
possible association between the presence of an inlet
patch and symptoms of globus or dysphagia.4,12,13
There is also limited data to suggest ablation of inlet
patch tissue with argon plasma coagulation reduces
these symptoms.14 In our observational study, we did
not find that patients with an inlet patch were any
more likely to have these symptoms than patients
without a patch. Results from prior studies may have
been biased by selection effects for inclusion in the
studies. Alternatively, perhaps only very large inlet
patches are associated with symptoms. Our study
did not find such an association, but we had limited
statistical power to detect associations with large inlet
patches as only 10 subjects were found to have a
patch occupying more than 25% of the circumference
of the esophageal lumen.
Our study has a number of limitations. We did not
obtain histological confirmation of inlet patches, and
the symptom questionnaires used were not validated.
We limited our analysis of tobacco use to only ciga-
rettes due to difficulty of quantifying equivalent
exposure to cigar smoke and pipe smoke. Our survey
did not query patients on smokeless tobacco prod-
ucts. Furthermore, we tested for multiple associa-
tions, so our finding might be solely due to chance.
Finally, our study was limited to a male population,
and 44% of the population were veterans, so these
results may not be generalizable to other populations.
In summary, in a cross-sectional study of men
undergoing upper endoscopy for research purposes,
we found that inlet patches are common, not associ-
ated with symptoms, but positively associated with
tobacco use and inversely associated with education.
Further studies are warranted to understand whether
inlet patches are acquired conditions andwhether they
cause esophageal symptoms in some individuals.
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